Medical marijuana showed effectiveness for chronic pain, chemo nausea, AIDS wasting, and MS spasms despite federal prohibition
A review argued that scientific evidence supported medical marijuana for chronic pain, chemotherapy nausea, AIDS wasting, and MS spasticity, and that ethical principles of beneficence supported physician prescribing.
Quick Facts
What This Study Found
The review examined the conflict between federal marijuana classification (Schedule I, no accepted medical use) and accumulating scientific evidence.
Studies showed medical marijuana was effective for controlling chronic non-cancer pain, alleviating chemotherapy-associated nausea and vomiting, treating AIDS wasting syndrome, and controlling MS muscle spasms. Benefits outweighed negative effects in patients who had failed other therapies.
At the time of publication, 16 states and the District of Columbia had legalized medical marijuana, creating a direct conflict with federal zero-tolerance policy.
The authors argued from bioethical principles that patients had a right to beneficial treatments, and denying physicians the ability to prescribe marijuana to suffering patients who had exhausted other options violated principles of beneficence and nonmaleficence.
Key Numbers
Medical marijuana was legal in 16 states plus DC at the time. Evidence supported efficacy in 4 major conditions. Federal classification remained Schedule I.
How They Did This
Narrative review of scientific evidence for medical marijuana efficacy combined with analysis of regulatory status and ethical framework based on bioethical principles.
Why This Research Matters
The review framed the medical marijuana debate in ethical terms, arguing that the gap between evidence and policy constituted a violation of patient rights and medical ethics.
The Bigger Picture
This review captured the state of the medical marijuana debate in 2011, where scientific evidence increasingly conflicted with federal drug policy, a tension that continued to evolve in subsequent years.
What This Study Doesn't Tell Us
Advocacy-oriented review rather than systematic evidence synthesis. Did not quantify the strength of evidence for each condition. Did not address potential harms in depth.
Questions This Raises
- ?How should federal drug classification evolve to reflect accumulating evidence?
- ?What regulatory framework would best balance patient access with safety monitoring?
Trust & Context
- Key Stat:
- 16 states had legalized medical marijuana against federal prohibition
- Evidence Grade:
- Narrative review combining scientific evidence with ethical analysis. Not a systematic review of efficacy data.
- Study Age:
- Published in 2011. The medical marijuana landscape has changed dramatically, with many more states and countries legalizing since.
- Original Title:
- Medical marijuana: medical necessity versus political agenda.
- Published In:
- Medical science monitor : international medical journal of experimental and clinical research, 17(12), RA249-61 (2011)
- Authors:
- Clark, Peter A, Capuzzi, Kevin, Fick, Cameron
- Database ID:
- RTHC-00475
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What conditions has medical marijuana been shown to help?
This review cited evidence for chronic non-cancer pain, chemotherapy-induced nausea and vomiting, AIDS wasting syndrome, and multiple sclerosis muscle spasms, particularly in patients who had not responded to other treatments.
Why was marijuana a Schedule I drug if it had medical uses?
The DEA classification was based on a 1970 decision. The review argued that subsequent evidence demonstrated medical benefits that warranted reclassification, and that maintaining Schedule I status denied patients access to a beneficial treatment.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- how-much-weed-legally-possess-state-guide
- crossing-state-lines-with-weed-legal-felony
- medical-card-worth-it-2026-benefits-costs
- how-much-weed-legally-grow-home-state-rules
Cite This Study
https://rethinkthc.com/research/RTHC-00475APA
Clark, Peter A; Capuzzi, Kevin; Fick, Cameron. (2011). Medical marijuana: medical necessity versus political agenda.. Medical science monitor : international medical journal of experimental and clinical research, 17(12), RA249-61.
MLA
Clark, Peter A, et al. "Medical marijuana: medical necessity versus political agenda.." Medical science monitor : international medical journal of experimental and clinical research, 2011.
RethinkTHC
RethinkTHC Research Database. "Medical marijuana: medical necessity versus political agenda..." RTHC-00475. Retrieved from https://rethinkthc.com/research/clark-2011-medical-marijuana-medical-necessity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.